Results 161 to 170 of about 108,892 (343)

Extended Stellar Populations in Ultrafaint Dwarf Galaxies

open access: yesThe Astronomical Journal
The possible existence of stellar halos in low-mass galaxies is being intensely discussed nowadays after some recent discoveries of stars located in the outskirts of dwarf galaxies of the Local Group.
Elisa A. Tau   +2 more
doaj   +1 more source

The properties of the stellar populations in ULIRGs â I. Sample, data and spectral synthesis modelling [PDF]

open access: bronze, 2009
J. Rodríguez Zaurín   +2 more
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Hidden Figures of Globular Clusters: Integrated Stellar Populations Impacted by Hot Subdwarfs

open access: yesThe Astrophysical Journal
Globular clusters (GCs) are fundamental for understanding the integrated light of old stellar populations and galaxy assembly processes. However, the role of hot, evolved stars, such as horizontal branch (HB), extreme HB, and blue stragglers, remains ...
Thayse A. Pacheco   +10 more
doaj   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

open access: yesMolecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié   +16 more
wiley   +1 more source

The LMC geometry and outer stellar populations from early DES data [PDF]

open access: bronze, 2015
E. Balbinot   +54 more
openalex   +1 more source

Home - About - Disclaimer - Privacy